Ferrer AL, Basavilvazo RMA, Lemus RR, Toca PL, Hernández VM

Language: Spanish
References: 20
Page: 477-483
PDF size: 68.41 Kb.

ABSTRACT

Background: Maternal mortality is considered a worldwide health problem, since the WHO has estimated that there are 500,000 maternal deaths annually and that the highest percentage of these deaths occurs in developed countries. It was not until 1970 that this problem became important, by revising the birth’s registrations and the maternal causes of morbidity and mortality, and that the mortality committees study began.
Objective: To determine the epidemiological profile and the trend of the maternal mortality in a urban hospital.
Material and methods: This retrospective and descriptive study was carried out at the Reproductive Health Coordination of the Centro Medico Nacional La Raza, through the registrations of the maternal deaths reported from 1993 to 2002 by the local committees of maternal mortality. Maternal mortality was defined as an event occurred during pregnancy or within 42 days after delivery, by any associated cause and aggravated by the same pregnancy. We used analytic and descriptive statistics, with central trend measurements, as well as chi square test.
Results: During the 10 years of analysis, 244 deaths were shown, with mean per year of 24.4 ± 5.2 deaths. Preeclampsia-eclampsia, hypovolemia and sepsis represented 71.7% of the cases. The highest number of deaths ranged from 30 to 34 years, with 64 deaths. Women with the first pregnancy had the highest number of deaths, with incidence of one maternal death for each 664.7 ± 135.6 new born in each year.
Discussion: The main maternal deaths per year corresponded to direct obstetric causes, with percentages from 53.3 to 86.9% annually, where preeclampsia-eclampsia syndrome maintains these high percentages, with a death average within the international standard parameters considered adequate.

REFERENCES

1. Boerna JT. Levels of maternal mortality in developing countries. Stud Fam Plann 1987;18:213-21.

2. McCarthy J. The conceptual framework of the PMM Network. Int J Gynaecol Obstet 1997;59:15-21.

3. Maine D. The strategic model for the PMM Network. Int J Gynaecol Obstet 1997;59:23-25.

4. Fathalla M, Rosenfield A, Indriso C, Sen D, Artnam S. Mortalidad materna. En: Manual sobre reproducción humana. FIGO 1993;3:85-104.

5. Velasco MV, Navarrete HE, Cardona PJA, Madrazo NM. Mortalidad materna en el Instituto Mexicano del Seguro Social 1987-1996. Rev Med IMSS 1997;35:377-83.

6. Liston WA, Kilpatrick DC. Is genetic susceptibility to pre-eclampsia conferred by homozygosity for the same single recessive gene in mother and fetus?. Br J Obstet Gynaecol 1991;98:1079-86.

7. Trejo RC. Mortalidad materna. Evolución de su estudio en México en los últimos 25 años. Ginecol Obstet Mex 1997;65:317-25.

8. Rebolledo CM, Zetina GTF, Espinoza de los Reyes V, Lascurain OA, Dominguez CV. Mortalidad materna en el Hospital de Gineco-Obstetricia Núm. 3 CMN La Raza. Ginecol Obstet Mex 1971;29:23-25.

9. Duthie SJ, Ma HK. Maternal mortality in Hong Kong 1986-1990. Br J Obstet Gynaecol 1994;101:906-7.

10. Bobadilla JL, Reyes FS, Karchmer S. La magnitud y las causas de la mortalidad materna en el Distrito Federal (1988-1989). Gac Med Mex 1996;132:5-18.

11. Atrash HK, Alexander S, Berg CJ. Maternal mortality in developed countries: not just a concern of the past. JAMA 1995;273:700-7.

12. Leitch CR, Cameron AD, Waker JJ. The changing pattern of eclampsia over a 60 years period. Br J Obstet Gynaecol 1997;10:917-22.

13. Centers for Disease Control and Prevention, Mortality Patterns-United States 1992. JAMA 1995;273:100-5.

14. Dima Abi-Said. Case-control study of risk factor for eclampsia. Am J Epidemiol 1995;142:437-41.

15. Jacques M, Jean-Claude F, Jean MM. Am J Obstet Gynecol 1993;169:501-8.

16. Arroyo P, Reynoso M, Casanueva E. Peso esperado para la talla y edad gestacional. Tablas de referencia. Ginecol Obstet Mex 1985;53:227-31.

17. Velasco MV, Navarrte HE, Pozos CJ, Cardona PJA. Mortalidad materna por preeclampsia-eclampsia en la región La Raza (1988-1997). Rev Med IMSS 1999;37:349-56.

18. Fernández CS, Gómez DH. Estadísticas en salud. Rev Med IMSS 2003;41:93-94.

19. Basavilvazo RA, Pacheco PC, Lemus RR, Martínez PJM, Martínez MA, Hernández-Valencia M. Complicaciones quirúrgicas maternas y perinatales en pacientes con plaquetopenia por síndrome de HELLP, en preeclampsia severa-eclampsia en terapia intensiva. Ginecol Obstet Mex 2003;71:379-86.

20. Hernández-Valencia M, Saldaña QL, Álvarez MM, Valdez ME. Los métodos de planificación familiar de barrera, como un factor de riesgo que predisponen a la presencia de preeclampsia. Ginecol Obstet Mex 2000;68:333-8.